On October 20, 2025, Berkshire Hathaway announced a definitive agreement to acquire Occidental Chemical Corporation (OxyChem) for $9.7 billion in cash. This move is widely viewed as a strategic deployment of Berkshire’s large cash reserves into a stable, cash-generating industrial asset, aligning with Warren Buffett’s value investing philosophy and providing predictable earnings in a high-valuation market environment. The acquisition is expected to close by the end of Q4 2025 and further diversifies Berkshire’s industrial holdings. The stock closed at $494.08 on October 20, 2025, up 0.34%, reflecting a positive but measured market reaction to the announcement, consistent with the broader market’s moderate gains.